About

Dr. Robert Brucker brings over 15 years of expertise in microbiology, drug discovery, and scientific leadership to Dovetail Biopartners. With a Ph.D. in Biomedicine from Vanderbilt University, he pioneered host-microbe interaction studies, followed by a Rowland Fellowship at Harvard, where he led innovative research on microbiome dynamics and immune responses. His academic and research achievements have been widely recognized, and his editorial role with Nature Frontiers in Microbiology reflects his influence in advancing microbial research. As co-founder and Chief Scientific Officer at DermBiont, Inc., Robert drove critical drug development programs, securing multi-million-dollar funding and launching clinical trials for microbiome-based therapeutics. He also served as a scientific advisor to InVaio Science, Seed Health, and others, where he applied his expertise in biotherapy, clinical assay development, and regulatory compliance. At Dovetail Biopartners, Robert’s comprehensive background in bioinformatics, big data, and clinical development underpins his strategic guidance, providing clients with robust solutions that address complex data and therapeutic challenges.In his tenure as a research associate at Harvard Medical School under the mentorship of Professor George Church, Kamesh led multiple high-impact projects and co-wrote grants that secured a total of $32 million in funding from the Department of Energy and the National Science Foundation. His work focused on recoding microbial genomes and incorporating non-canonical amino acids in E.coli. His work has consistently demonstrated a keen ability to transform complex biotech endeavors in the wet-lab into actionable insights through robust and reproducible analysis of experiments workflows. As a Senior Consultant at Dovetail Biopartners, Kamesh leverages his extensive experience to provide strategic guidance for protein and enzyme engineering campaigns. Kamesh offers expertise in computational protein design (both ML and physics based) and in directed evolution based methods in the wet-lab. His deep understanding of the protein engineering space, genetic code expansion technology, and computational protein design ensures a pragmatic and solutions-oriented approach for projects of varying complexity, budgets, resources and timelines.